Reduction in Surface Contamination with Antineoplastic Drugs in 22 Hospital Pharmacies in the US Following Implementation of a Closed-system Drug Transfer Device

Overview

Journal J Oncol Pharm Pract

Publisher Sage Publications

Specialties Oncology
Pharmacy

Date 2010 Feb 17

PMID 20156932

Citations 42

Authors

Paul J M Sessink

Thomas H Connor

James A Jorgenson

Timothy G Tyler

Affiliations

Soon will be listed here.

Abstract

Purpose: Surface contamination with the antineoplastic drugs cyclophosphamide, ifosfamide, and 5-fluorouracil was compared in 22 US hospital pharmacies following preparation with standard drug preparation techniques or the PhaSeal® closed-system drug transfer device (CSTD).

Methods: Wipe samples were taken from biological safety cabinet (BSC) surfaces, BSC airfoils, floors in front of BSCs, and counters and analyzed for contamination with cyclophosphamide, ifosfamide, and 5-fluorouracil. Contamination was reassessed several months after the implementation of the CSTD. Surface contamination (ng/cm(2)) was compared between the two techniques and evaluated with the Signed Rank Test.

Results: Using the CSTD compared to the standard preparation techniques, a significant reduction in levels of contamination was observed for all drugs (cyclophosphamide: p < 0.0001; ifosfamide: p < 0.001; 5-fluorouracil: p < 0.01). Median values for surface contamination with cyclophosphamide, ifosfamide, and 5-fluorouracil were reduced by 95%, 90%, and 65%, respectively.

Conclusions: Use of the CSTD significantly reduces surface contamination when preparing cyclophosphamide, ifosfamide, and 5-fluorouracil as compared to standard drug preparation techniques.

Citing Articles

Evaluation of environmental antibiotic contamination by surface wipe sampling in a large care centre.

Sessink P, Tans B, Devolder D, Schrijvers R, Spriet I J Antimicrob Chemother. 2024; 79(7):1637-1644.

PMID: 38828950 PMC: 11215530. DOI: 10.1093/jac/dkae159.

Exposure Assessment and Monitoring of Antiblastic Drugs Preparation in Health Care Settings: A Systematic Review.

Borghi F, Zellino C, Zago A, De Vito G, Del Vecchio R, Cattaneo A Med Lav. 2024; 115(2):e2024012.

PMID: 38686575 PMC: 11181217. DOI: 10.23749/mdl.v115i2.15609.

A LC-MS/MS based methodology for the environmental monitoring of healthcare settings contaminated with antineoplastic agents.

Charlier B, Coglianese A, De Rosa F, Cozzolino A, Boccia G, Borrelli A J Public Health Res. 2023; 12(1):22799036231160629.

PMID: 36923326 PMC: 10009035. DOI: 10.1177/22799036231160629.

Evaluation of long-term data on surface contamination by antineoplastic drugs in pharmacies.

Quartucci C, Rooney J, Nowak D, Rakete S Int Arch Occup Environ Health. 2023; 96(5):675-683.

PMID: 36877242 PMC: 10219872. DOI: 10.1007/s00420-023-01963-y.

LC-MS-MS Determination of Cytostatic Drugs on Surfaces and in Urine to Assess Occupational Exposure.

Lema-Atan J, Lendoiro E, Paniagua-Gonzalez L, Cruz A, Lopez-Rivadulla M, de-Castro-Rios A J Anal Toxicol. 2022; 46(9):e248-e255.

PMID: 36164930 PMC: 9872221. DOI: 10.1093/jat/bkac073.

References

Crauste-Manciet S, Sessink P, Ferrari S, Jomier J, Brossard D . Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators. Ann Occup Hyg. 2005; 49(7):619-28. DOI: 10.1093/annhyg/mei045. View

Sessink P, Anzion R, van den Broek P, Bos R . Detection of contamination with antineoplastic agents in a hospital pharmacy department. Pharm Weekbl Sci. 1992; 14(1):16-22. DOI: 10.1007/BF01989220. View

Sottani C, Turci R, Perbellini L, Minoia C . Liquid-liquid extraction procedure for trace determination of cyclophosphamide in human urine by high-performance liquid chromatography tandem mass spectrometry. Rapid Commun Mass Spectrom. 1998; 12(16):1063-8. DOI: 10.1002/(SICI)1097-0231(19980831)12:16<1063::AID-RCM287>3.0.CO;2-K. View

Pethran A, Schierl R, Hauff K, Grimm C, Boos K, Nowak D . Uptake of antineoplastic agents in pharmacy and hospital personnel. Part I: monitoring of urinary concentrations. Int Arch Occup Environ Health. 2003; 76(1):5-10. DOI: 10.1007/s00420-002-0383-8. View

Valanis B, Vollmer W, Labuhn K, Glass A . Occupational exposure to antineoplastic agents and self-reported infertility among nurses and pharmacists. J Occup Environ Med. 1997; 39(6):574-80. DOI: 10.1097/00043764-199706000-00013. View

McDonald A, McDonald J, Armstrong B, Cherry N, Cote R, Lavoie J . Congenital defects and work in pregnancy. Br J Ind Med. 1988; 45(9):581-8. PMC: 1009659. DOI: 10.1136/oem.45.9.581. View

Rubino F, Floridia L, Pietropaolo A, Tavazzani M, Colombi A . Measurement of surface contamination by certain antineoplastic drugs using high-performance liquid chromatography: applications in occupational hygiene investigations in hospital environments. Med Lav. 1999; 90(4):572-83. View

Sorsa M, Pyy L, Salomaa S, Nylund L, Yager J . Biological and environmental monitoring of occupational exposure to cyclophosphamide in industry and hospitals. Mutat Res. 1988; 204(3):465-79. DOI: 10.1016/0165-1218(88)90042-0. View

Harrison B, Peters B, Bing M . Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques. Am J Health Syst Pharm. 2006; 63(18):1736-44. DOI: 10.2146/ajhp050258. View

10.

Turci R, Micoli G, Minoia C . Determination of methotrexate in environmental samples by solid phase extraction and high performance liquid chromatography: ultraviolet or tandem mass spectrometry detection?. Rapid Commun Mass Spectrom. 2000; 14(8):685-91. DOI: 10.1002/(SICI)1097-0231(20000430)14:8<685::AID-RCM937>3.0.CO;2-2. View

11.

Hemminki K, Kyyronen P, Lindbohm M . Spontaneous abortions and malformations in the offspring of nurses exposed to anaesthetic gases, cytostatic drugs, and other potential hazards in hospitals, based on registered information of outcome. J Epidemiol Community Health. 1985; 39(2):141-7. PMC: 1052422. DOI: 10.1136/jech.39.2.141. View

12.

Turci R, Sottani C, Ronchi A, Minoia C . Biological monitoring of hospital personnel occupationally exposed to antineoplastic agents. Toxicol Lett. 2002; 134(1-3):57-64. DOI: 10.1016/s0378-4274(02)00163-7. View

13.

Sessink P, Friemel N, Anzion R, Bos R . Biological and environmental monitoring of occupational exposure of pharmaceutical plant workers to methotrexate. Int Arch Occup Environ Health. 1994; 65(6):401-3. DOI: 10.1007/BF00383251. View

14.

Hedmer M, Georgiadi A, Bremberg E, Jonsson B, Eksborg S . Surface contamination of cyclophosphamide packaging and surface contamination with antineoplastic drugs in a hospital pharmacy in Sweden. Ann Occup Hyg. 2005; 49(7):629-37. DOI: 10.1093/annhyg/mei042. View

15.

Sessink P, Van de Kerkhof M, Anzion R, Noordhoek J, Bos R . Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: is skin absorption an important exposure route?. Arch Environ Health. 1994; 49(3):165-9. DOI: 10.1080/00039896.1994.9940377. View

16.

Sessink P, Wittenhorst B, Anzion R, Bos R . Exposure of pharmacy technicians to antineoplastic agents: reevaluation after additional protective measures. Arch Environ Health. 1997; 52(3):240-4. DOI: 10.1080/00039899709602893. View

17.

Valanis B, Hertzberg V, Shortridge L . Antineoplastic drugs. Handle with care. AAOHN J. 1987; 35(11):487-92. View

18.

Schmaus G, Schierl R, Funck S . Monitoring surface contamination by antineoplastic drugs using gas chromatography-mass spectrometry and voltammetry. Am J Health Syst Pharm. 2002; 59(10):956-61. DOI: 10.1093/ajhp/59.10.956. View

19.

Valanis B, Vollmer W, Labuhn K, Glass A . Acute symptoms associated with antineoplastic drug handling among nurses. Cancer Nurs. 1993; 16(4):288-95. View

20.

Valanis B, Vollmer W, Labuhn K, Glass A . Association of antineoplastic drug handling with acute adverse effects in pharmacy personnel. Am J Hosp Pharm. 1993; 50(3):455-62. View